C reactive protein and alpha1-antitrypsin: relationship between levels and gene variants
Authors:
- Stefania OttavianiSOStefania Ottaviani
- Zamir KadijaZKZamir Kadija
- Elena ParacchiniEPElena Paracchini
- Francesca MarianiFMFrancesca Mariani
- Maurizio LuisettiMLMaurizio Luisetti
- 1 June 2011
- journal article
- Published by Elsevier in Translational Research
- Vol. 157 (6) , 332-338
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Outcomes for COPD pharmacological trials: from lung function to biomarkersEuropean Respiratory Journal, 2008
- Role of the soluble pattern recognition receptor PTX3 in vascular biologyJournal of Cellular and Molecular Medicine, 2007
- C-reactive Protein as a Predictor of Prognosis in Chronic Obstructive Pulmonary DiseaseAmerican Journal of Respiratory and Critical Care Medicine, 2007
- Pulmonary Biomarkers in Chronic Obstructive Pulmonary DiseaseAmerican Journal of Respiratory and Critical Care Medicine, 2006
- C-reactive protein in patients with COPD, control smokers and non-smokersThorax, 2005
- 1-Antitrypsin deficiency {middle dot} 1: Epidemiology of 1-antitrypsin deficiencyThorax, 2004
- American Thoracic Society/European Respiratory Society Statement: Standards for the Diagnosis and Management of Individuals with Alpha-1 Antitrypsin DeficiencyAmerican Journal of Respiratory and Critical Care Medicine, 2003
- The global burden of disease, 1990–2020Nature Medicine, 1998
- The major acute phase reactants: C-reactive protein, serum amyloid P component and serum amyloid A proteinImmunology Today, 1994
- HUMAN PLASMA PROTEINASE INHIBITORSAnnual Review of Biochemistry, 1983